Mesenchymal Stem Cell Allograft Improved Pain Management in Dogs with Osteoarthritis
Mesenchymal Stem Cell Allograft Improved Pain Management in Dogs with Osteoarthritis作者机构：Department of Surgery University of California Irvine Irvine USA Department of Biomedical Engineering University of California Irvine Irvine USA Department of Pancreatic Surgery General Surgery Qilu Hospital of Shandong University Jinan China European Wellness Biomedical Group Edenkoben Germany Baden R&D Laboratories GmbH Sabine Conrad Ferdinand-Laselle-Strasse Edenkoben Germany Crestwood Veterinary Clinic Edmonton Canada
出 版 物：《Journal of Biosciences and Medicines》 (生物科学与医学（英文）)
年 卷 期：2023年第11卷第11期
页 面：181-189页
学科分类：1001[医学-基础医学(可授医学、理学学位)] 100101[医学-人体解剖与组织胚胎学] 10[医学]
主 题：Stem Cell Therapy Canine Pain Osteoarthritis Mesenchymal Stem Cell
摘 要：Background: Osteoarthritis is one of the most common bone diseases, triggered by bone destruction stemming from the inflammatory response of chondrocytes. The disease progresses slowly, but halting its progression or finding a cure remains elusive. The treatment of pain associated with osteoarthritis has yielded unsatisfactory results. In recent years, mesenchymal stem cells (MSCs) have emerged as a potential avenue for addressing the condition. In this study, we used MSCs to treat companion dogs with osteoarthritis. Methods: For this study, 26 animals were included in this study to assess the pain and mobility one month after treatment. The pain scores were obtained from owners using a questionnaire based on the Helsinki Chronic Pain Index, and the Liverpool Osteoarthritis in Dogs (LOAD) Owner questionnaire to assess the mobility of the dogs from stem cell infusion. Results: Questionnaires were administered to dog owners before and one month after treatment, and we found that dogs treated with MSCS experienced an 81.2% ± 6.8% reduction in pain and a 77.9% ± 10.1% increase in mobility, whereas most of the dogs in the untreated control group experienced disease progression. Conclusions: The transplantation of stem cells into companion pets is a promising and expanding opportunity for pet owners with aging and arthritic dogs. MSCs may play an important role in the treatment of OA without complications in companion pets.
维普期刊数据库